We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$6.05B
AUM Growth
+$143M
Cap. Flow
-$206M
Cap. Flow %
-3.42%
Top 10 Hldgs %
48.47%
Holding
77
New
14
Increased
23
Reduced
24
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 62.04%
2 Technology 9.78%
3 Communication Services 7.21%
4 Materials 6.27%
5 Industrials 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APTV icon
26
Aptiv
APTV
$10.3B
$81.9M 1.35%
520,513
+307,607
+144% +$45.1M
NSC icon
27
Norfolk Southern
NSC
$75.2B
$76.3M 1.26%
287,571
+88,814
+45% +$24.5M
MYGN icon
28
Myriad Genetics
MYGN
$308M
$75.7M 1.25%
2,476,080
-93,353
-4% -$2.7M
UNP icon
29
Union Pacific
UNP
$174B
$75.6M 1.25%
343,540
+25,434
+8% +$5.66M
MOH icon
30
Molina Healthcare
MOH
$10.2B
$75.3M 1.25%
297,419
-6,604
-2% -$1.66M
BFLY icon
31
Butterfly Network
BFLY
$2.5B
$71.9M 1.19%
4,964,751
+189,905
+4% +$2.56M
AMZN icon
32
Amazon
AMZN
$2.94T
$71M 1.18%
+413,040
New +$68.6M
DVA icon
33
DaVita
DVA
$11.4B
$69M 1.14%
573,096
+146,839
+34% +$17.4M
HUM icon
34
Humana
HUM
$44.8B
$67.5M 1.12%
152,461
-41,477
-21% -$18.1M
ELV icon
35
Elevance Health
ELV
$84.7B
$65.9M 1.09%
172,713
-90,920
-34% -$34.7M
IS
36
DELISTED
ironSource Ltd.
IS
$53.7M 0.89%
+5,116,826
New +$55M
HOLX
37
DELISTED
Hologic
HOLX
$52.6M 0.87%
788,788
+361,343
+85% +$24.2M
LGV.U
38
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$50.4M 0.83%
5,000,000
V icon
39
Visa
V
$677B
$49.8M 0.82%
212,791
-39,396
-16% -$9.01M
SABR icon
40
Sabre
SABR
$803M
$48.3M 0.8%
3,870,698
+684,994
+22% +$9.63M
NSP icon
41
Insperity
NSP
$1.94B
$47.8M 0.79%
529,372
+152,766
+41% +$13.6M
BHVN
42
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$43.2M 0.71%
444,701
-13,899
-3% -$1.13M
IQV icon
43
IQVIA
IQV
$40.1B
$37.6M 0.62%
155,329
-51,718
-25% -$11.9M
MDT icon
44
Medtronic
MDT
$116B
$33.3M 0.55%
267,912
+152,796
+133% +$19.2M
MTOR
45
DELISTED
MERITOR, Inc.
MTOR
$31.9M 0.53%
1,363,967
+289,400
+27% +$7.6M
BABA icon
46
Alibaba
BABA
$306B
$31.5M 0.52%
+138,845
New +$30.8M
ATIP
47
DELISTED
ATI Physical Therapy, Inc.
ATIP
$30.6M 0.51%
64,082
+23
+0% +$11.4K
CCC
48
CCC Intelligent Solutions
CCC
$4.05B
$30M 0.5%
+3,015,676
New +$30.4M
ENDP
49
DELISTED
Endo International plc
ENDP
$25.1M 0.42%
5,370,384
+500,000
+10% +$2.87M
UBER icon
50
Uber
UBER
$160B
$23.1M 0.38%
+460,592
New +$24.1M

Similar funds

Glenview Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Glenview Capital Management held 77 positions worth $6.05B, up 2.4% from $5.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Glenview Capital Management withdrew a net $206M in Q2 2021, closing 12 positions and reducing 24 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $135M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 68% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Glenview Capital Management opened a new position in Centene worth $147M.

  • Glenview Capital Management's largest Q2 2021 buy was Centene: 2,020,967 shares worth $147M.
  • Glenview Capital Management added most to Paramount Global Class B in Q2 2021, an estimated $160M increase.
  • Glenview Capital Management's biggest Q2 2021 reduction was Tenet Healthcare, cutting an estimated $191M.
  • Glenview Capital Management fully exited Nuance Communications, Inc. in Q2 2021, selling an estimated $135M.
  • Glenview Capital Management's ten largest holdings make up 48% of its $6.05B portfolio in Q2 2021.
  • Glenview Capital Management opened 14 new positions and closed 12 in Q2 2021.
  • Glenview Capital Management's portfolio value rose 2.4% quarter-over-quarter to $6.05B.

Based on Glenview Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.